Machine learning potential predictor of idiopathic pulmonary fibrosis

被引:0
|
作者
Ding, Chenchun [1 ]
Liao, Quan [1 ]
Zuo, Renjie [1 ]
Zhang, Shichao [2 ]
Guo, Zhenzhen [3 ]
He, Junjie [1 ]
Ye, Ziwei [3 ]
Chen, Weibin [1 ]
Ke, Sunkui [1 ]
机构
[1] Xiamen Univ, Zhongshan Hosp, Sch Med, Dept Thorac Surg, Xiamen, Fujian, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China
[3] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
bioinformatics; biomarkers; immune cell infiltration; machine-learning; idiopathic pulmonary fibrosis;
D O I
10.3389/fgene.2024.1464471
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction Idiopathic pulmonary fibrosis (IPF) is a severe chronic respiratory disease characterized by treatment challenges and poor prognosis. Identifying relevant biomarkers for effective early-stage risk prediction is therefore of critical importance.Methods In this study, we obtained gene expression profiles and corresponding clinical data of IPF patients from the GEO database. GO enrichment and KEGG pathway analyses were performed using R software. To construct an IPF risk prediction model, we employed LASSO-Cox regression analysis and the SVM-RFE algorithm. PODNL1 and PIGA were identified as potential biomarkers associated with IPF onset, and their predictive accuracy was confirmed using ROC curve analysis in the test set. Furthermore, GSEA revealed enrichment in multiple pathways, while immune function analysis demonstrated a significant correlation between IPF onset and immune cell infiltration. Finally, the roles of PODNL1 and PIGA as biomarkers were validated through in vivo and in vitro experiments using qRT-PCR, Western blotting, and immunohistochemistry.Results These findings suggest that PODNL1 and PIGA may serve as critical biomarkers for IPF onset and contribute to its pathogenesis.Discussion This study highlights their potential for early biomarker discovery and risk prediction in IPF, offering insights into disease mechanisms and diagnostic strategies.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF USING A NOVEL MACHINE LEARNING ALGORITHM TO DIAGNOSE IDIOPATHIC PULMONARY FIBROSIS
    Cadham, C.
    Reicher, J.
    Muelly, M.
    Hutton, D. W.
    VALUE IN HEALTH, 2023, 26 (06) : S72 - S72
  • [22] Diagnosis accuracy of machine learning for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Li Cong
    Ying Chen
    Xiaolei He
    MaiLiKai KuErBan
    Chao Wu
    Liping Chen
    European Journal of Medical Research, 30 (1)
  • [23] Network Pharmacology and Machine Learning Reveal Salidroside's Mechanisms in Idiopathic Pulmonary Fibrosis Treatment
    Ding, Chenchun
    Guo, Zhenzhen
    Liao, Quan
    Zuo, Renjie
    He, Junjie
    Ye, Ziwei
    Chen, Weibin
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 9453 - 9467
  • [24] Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
    Furukawa, Taiki
    Oyama, Shintaro
    Yokota, Hideo
    Kondoh, Yasuhiro
    Shiratori, Yoshimune
    Hasegawa, Yoshinori
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Lung cancer associated to idiopathic pulmonary fibrosis: predictor ranking and mining
    Lettieri, S.
    Coretti, M.
    Mariani, F.
    Bortolotto, C.
    Agustoni, F.
    Lancia, A.
    Rinaldi, P.
    Primiceri, C.
    Piloni, D.
    Saracino, L.
    Stella, G. M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [26] Right ventricular strain: An independent predictor of survival in idiopathic pulmonary fibrosis
    D'Andrea, Antonello
    Stanziola, Anna
    D'Alto, Michele
    Di Palma, Enza
    Martino, Maria
    Scarafile, Raffaella
    Molino, Antonio
    Rea, Gaetano
    Maglione, Marco
    Calabro, Raffaele
    Russo, Maria Giovanna
    Bossone, Eduardo
    Saggar, Rajeev
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 908 - 910
  • [27] Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis
    Nathan, Steven D.
    Shlobin, Oksana A.
    Barnett, Scott D.
    Saggar, Rajeev
    Belperio, John A.
    Ross, David J.
    Ahmad, Shahzad
    Saggar, Rajan
    Libre, Eric
    Lynch, Joseph P., III
    Zisman, David A.
    RESPIRATORY MEDICINE, 2008, 102 (09) : 1305 - 1310
  • [28] Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosis
    Ohshimo, Shinichiro
    Kida, Yoshiko
    Kyo, Michihito
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Hamada, Hironobu
    Hattori, Noboru
    Bonella, Francesco
    Guzman, Josune
    Costabel, Ulrich
    Shime, Nobuaki
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [29] Potential role of statin use in idiopathic pulmonary fibrosis
    Santana, Alfredo N. C.
    Kairalla, Ronaldo A.
    Carvalho, Carlos R. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (09) : 1048 - 1048
  • [30] Investigating the Potential Origins of the Myofibroblast in Idiopathic Pulmonary Fibrosis
    Walsh, S. M.
    Worrell, J. C.
    Boylan, D. A.
    Lumsden, R.
    Fabre, A.
    Kane, R.
    Keane, M. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S517 - S517